Navigation Links
Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
Date:10/29/2008

Predictive model shows shots would also save $7 billion in related health-care costs

WEDNESDAY, Oct. 29 (HealthDay News) -- Vaccinating infants with what's known as the "7 valent pneumococcal conjugate vaccine" (PCV7) could save more than 357,000 lives and $7 billion in costs by preventing bacterial infections during a flu pandemic, according to a predictive model developed by U.S. researchers.

Pneumococcal disease (such as meningitis) and other bacterial infections can follow flu and cause secondary infections that worsen flu symptoms and increase the risk of flu-related death. For example, it's believed that bacterial infections caused almost half of the deaths of young soldiers during the 1918 worldwide flu pandemic, according to background information in an Emory University news release.

"We've known for years that bacterial infections can develop after influenza. Unlike the 1918 flu pandemic, which preceded the antibiotic era, we now have vaccines that can prevent these types of pneumococcal infections. This model shows what a dramatically different outcome we could expect with standard PCV vaccination," Keith P. Klugman, professor of global health at Emory's Rollins School of Public Health, said in the news release.

He and colleagues at Harvard University, i3 Innovus in Medford. Mass., and Wyeth Research created a model to estimate the public health and economic effect current influenza vaccination practices would have on children younger than two years old during a flu pandemic. Since 2000, the Centers for Disease Control and Prevention has recommended PCV vaccinations for infants and children.

The model showed that current PCV vaccination practices lower costs in a typical flu season by $1.4 billion and would cut costs by $7 billion in a pandemic. It also predicted that PCV vaccination would prevent 1.24 million cases of pneumonia and 357,000 pneumococcal-related deaths in a pandemic.

The findings were presented this week at an infectious diseases conference in Washington, D.C.

"Our research shows that routine pneumococcal vaccination is a proactive approach that can greatly reduce the effects of a future flu pandemic," Klugman said. "Countries that have not yet implemented a pneumococcal vaccination program may want to consider this as part of their pandemic flu preparedness."

Klugman is a paid consultant for Wyeth Pharmaceuticals, which funded the study.

More information

The Immunization Action Coalition has more about pneumococcal diseases.



-- Robert Preidt



SOURCE: Emory University, news release, Oct. 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Shamanic Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation ... and body, these individual customized retreats offer the winter-weary soul an excellent opportunity ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has ... a company involved in the underground testing of nuclear weapons. Years later, when her ... Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by ...
(Date:2/27/2017)... ... 27, 2017 , ... Orange County dentist, Dr. A. Rassouli, comments ... occurs when the bacteria in plaque infect the gums and other tissues supporting the ... root planing or SRP, and can include surgical therapies if the condition has led ...
(Date:2/27/2017)... ... , ... Miro is the ultimate smart media center that offers a fascinating ... shows and much more apps for user exploration. Its innovative acoustic design with premium ... x 720 provides crisp images with remarkable clarity and color. The WiFi connection enables ...
(Date:2/27/2017)... Houston, TX (PRWEB) , ... February 27, 2017 ... ... the 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential ... Volterra Energy LLC in March 2014. The company had 800 customers and 2,250 ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology: